CSIMarket Company Name, Ticker, Industry, else..
 

Aptinyx Inc   (NASDAQ: APTX)

Aptinyx Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

APTX Sales vs. its Competitors Q1 2023


Comparing the current results to its competitors, Aptinyx Inc reported Revenue decrease in the 1 quarter 2023 year on year by 0 %, slower than the combined decrease of the APTX's competitors by -9.58 %, recorded in the same quarter.

• List of APTX Competitors





Revenue Growth Comparisons




Net Income Comparison

Aptinyx Inc , slower than the average decrease reported by the company's competitors of -55.54 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -55.54 %

<<  APTX Stock Performance Comparisons





*Market share is calculated based on total revenue.





Publicly Traded Peers of Aptinyx Inc




Tiziana Life Sciences Ltd
Share Performance



-50.97%
One Year
Tiziana Life Sciences Ltd
Profile

Tiziana Life Sciences Ltd's business model focuses on the development and commercialization of innovative therapeutics in the field of immunology and oncology.

More about Tiziana Life Sciences Ltd's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ - mill. $ -18.431 mill.


Altamira Therapeutics Ltd
Share Performance



-30.88%
Over The Past 5 Days
Altamira Therapeutics Ltd
Profile

Altamira Therapeutics Ltd's business model revolves around developing and commercializing innovative therapeutics.

More about Altamira Therapeutics Ltd 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ - mill. $ 0.000 mill.


Calcimedica Inc
Share Performance



+197.62%
30 Days
Calcimedica Inc
Profile

Calcimedica Inc is a biopharmaceutical company that focuses on the research and development of small molecule drugs to treat a range of diseases caused by calcium dysregulation. Their business model involves identifying potential drug candidates, conducting preclinical and clinical trials, and eventually commercializing these drugs to address unmet medical needs.

More about Calcimedica Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 29.926 mill. $ - mill. $ -21.240 mill.


Xbiotech Inc
Share Performance



-0.91%
Over The Past 5 Days
Xbiotech Inc
Profile

Xbiotech Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic antibodies. They seek to address unmet medical needs by leveraging their proprietary True Human antibody technology.

More about Xbiotech Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 66.158 mill. $ - mill. $ -45.133 mill.


Edesa Biotech Inc
Share Performance



-3.14%
Over The Past 5 Days
Edesa Biotech Inc
Profile

Edesa Biotech Inc's business model focuses on the development and commercialization of innovative therapeutics in the field of dermatology and gastrointestinal diseases.

More about Edesa Biotech Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 36.120 mill. $ - mill. $ -14.102 mill.

111 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Aptinyx Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Aptinyx Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.